Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

DISEASE RELATED DEATHS AND ITS PREDICTING FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA

Jasna Mihailovic
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1450;
Jasna Mihailovic
1Oncology Institute of Vojvodina Sremska Kamenica
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1450

Objectives The aim of the study was to analyze the mortality rate and predicting factors which influenced the disease related deaths (DRD) in patients with differentiated thyroid carcinoma (DTC) in a 45-year follow-up study.

Methods From 1968 to 2000 363 DTC patients underwent initial thyroid surgery in a different hospitals throughout the country. All of them underwent therapy with I-131 in our institution and were monitored until the end of 2015. Among 363 patients, 52 were lost to follow-up. Predicting factors were calculated by the Kaplan-Meier method and Log-rank test.

Results Out of 311, 96 (31%) patients have died during the course of the disease: 36 (37.5%) man and 60 (62.5%) woman aged from 8 to 74 years (mean, 52.9 years). Out of 311 DTC, there were 63 (20.3%) DRD, while 33 patients died due to other causes of deaths. DRD was significantly influenced by patients’age (p=0.001) and nodal and/or distal metastases (p=0.000), while following factors had no influence to cause of death: type of the initial treatment, gender, histology of the tumor and recurrent disease (p=0.863, p=0.956, p=0.870, and p=0.827, respectively).

Conclusions Disease related deaths occurred significantly more frequent in patients older than 45 years than in patients younger than 45 years. Presence of nodal and distal metastases has also significant influence on DRD. Patients with DTC should be adequately treated and life-long monitored.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 57, Issue supplement 2
May 1, 2016
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
DISEASE RELATED DEATHS AND ITS PREDICTING FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
DISEASE RELATED DEATHS AND ITS PREDICTING FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
Jasna Mihailovic
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1450;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
DISEASE RELATED DEATHS AND ITS PREDICTING FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA
Jasna Mihailovic
Journal of Nuclear Medicine May 2016, 57 (supplement 2) 1450;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

MTA I: Radiopharmaceutical Therapy Posters

  • Imaging and biochemical predictive biomarkers of overall survival and treatment response in patients receiving 223Ra-dichloride treatment in clinical practice
  • SUVmax of the FDG-avid metastatic lesions before I-131 therapy for differentiated thyroid carcinoma is a powerful independent prognostic factor
  • Long-term outcomes of 125 patients with stage IV pheochromocytoma or paraganglioma treated with 131I-MIBG
Show more MTA I: Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire